Healthcare stocks have jumped into pricey territory. Anyone looking to buy in now might want to consider the laggards. The ...

Here are 10 of the best health care stocks to buy in 2024, according to CFRA analysts: *As of Sept. 10 close. Based on ...

What’s next for Akeso and Summit Therapeutics after their cancer immunotherapy outperformed Merck’s Keytruda in a large Phase 3 clinical trial? Who’s the iconoclastic outsider behind Summit ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Based in Rahway, Merck (MRK) is in the Medical sector, and so far this year, shares have seen a price change of 5.61%. The pharmaceutical company is paying out a dividend of $0.77 per share at the ...

Merck and Siemens have signed a strategic partnership to accelerate digital transformation in manufacturing through smart, ...

Merck & Co.’s best-selling drug Keytruda helped ... The findings, presented Sunday at the European Society for Medical Oncology Congress in Barcelona, show the initial benefits seen with ...

In 2021, the FDA blasted Merck for using a premature endpoint to ... The results will be presented at the European Society for Medical Oncology (ESMO) 2024 annual meeting. The overall survival ...

Merck broke down the results Friday at the European Society of Medical Oncology Congress in Barcelona. In an email, the company pointed out that the majority of patients in LITESPARK-005 received ...

Investorideas.com ( a go-to investing platform, releases the second of a two-part series looking at news and developments for the treatment of cancer and solid tumors focusing on immunotherapy, ...